This article is more than 5 years old. Information may no longer be current.
MD Anderson names pediatrics department chairman
Click Here to Manage Email Alerts
Richard Gorlick, MD, has been named division head and department chair of pediatrics at The University of Texas MD Anderson Cancer Center.
Gorlick, a pediatric cancer survivor, has focused his research and clinical efforts on sarcomas. His laboratory strives to identify targeted therapies and new drugs for childhood cancers, as well as to understand the mechanisms that drive the development and progression of osteosarcoma, the most common form of bone cancer in children.
“Dr. Gorlick is a leader of great stature who will further inspire our institutional commitment for pediatric oncology while serving our youngest and most vulnerable patients with a focus on excellence and compassion,” Ronald A. DePinho, MD, president of MD Anderson, said in a press release. “We are extremely pleased that the children, adolescents and young adults for whom we have the honor of caring and their families will benefit from Dr. Gorlick’s extensive clinical and research experience.”
Gorlick previously served as division chief of pediatric hematology–oncology and vice chairman of pediatrics at The Children’s Hospital and Montefiore, as well as professor of pediatrics and molecular pharmacology at The Albert Einstein College of Medicine.
“I am immensely excited to serve as the division head of pediatrics at MD Anderson, where the tremendous institutional strengths in fields such as immunotherapy and genetic profiling can be applied to pediatric cancers in unique ways with the support of our medical oncology colleagues tackling related illnesses,” Gorlick said in the press release.